MedTrace Logo

Let´s Talk About Sleep in College Student

NCT05265494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-01-18

No results posted yet for this study

Summary

The concern about the quality of sleep of university students, future professionals of the world, must be crucial for the scientific community, as well as for university professors and professors. Innovative electrotherapy technologies such as non-invasive neuromodulation NESA are demonstrating effects on improving sleep quality, concentration and stress, so the objective of this project is to carry out a triple-blind randomized clinical trial with first-year science science students. health from three universities. The design is made up of an intervention group with NESA technology and another control group in each of the centers. Where the quality of sleep, perception of stress, cortisol levels in saliva and academic performance will be analyzed.

This multicenter project hopes to demonstrate that non-invasive NESA neuromodulation can be a preventive treatment for the maintenance of sleep quality during stressful periods such as university exams, as well as being able to modulate perceived stress and translate into an improvement in student performance.

Conditions

  • Stress
  • Sleep Disturbance

Interventions

DEVICE

Non invasive neuromodulation NESA (XSIGNAL device)

The study volunteers are treated with the NXSIGNAL® device in sessions of 60 minutes, twice a week and for 5 weeks (10 sessions). • The skin must be clean, free of creams and grease, lectrodes are connected to the control console and the targeting electrode located in over the intervertebral area between C7 and T1 (cervical area) and will follow the central treatment pattern with the following combination: * 2 sessions: Program 1 (30 min), Program 7 (15min) and Program 8 (15min). * 4 sessions: Program 2 (15min), Program 7 (30 min) and Program 8 (15min) * 4 sessions: Program 7 (60min)

Sponsors & Collaborators

  • Alfonso X El Sabio University

    collaborator OTHER

  • University of Alcala

    collaborator OTHER

  • University Pontifical of Salamanca

    collaborator UNKNOWN

  • University of Las Palmas de Gran Canaria

    lead OTHER

Principal Investigators

  • Raque l I Medina Ramírez, PhD · University of Las Palmas de Gran Canaria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2023-01-16
Completion
2023-01-16

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05265494 on ClinicalTrials.gov